Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

Oncogene

Volumn 23, Issue 32, 2004, Pages 5513-5522

  Knight Krajewski, Selena ^a   Welsh, Catherine F ^a,b   Liu, Yunqi ^a   Lyons, Leah S ^a   Faysal, Joanne M ^a   Yang, Eddy S ^a   Burnstein, Kerry L ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Cdc42; Cell cycle; Cyclin dependent kinase inhibitor; p21; Rac1; Rho GTPases

Indexed keywords

PROTEIN CDC42; PROTEIN P21; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CANCER CELL; CANCER MODEL; CELL CYCLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION;

ANDROGENS; CDC2-CDC28 KINASES; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; MALE; PROSTATIC NEOPLASMS; RAC1 GTP-BINDING PROTEIN;

EID: 3843074330     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207708     Document Type: Article

References (65)

1. Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M and Kosma VM. (1999). Prostate, 39, 8-15.
2. Adnane J, Bizouarn FA, Qian Y, Hamilton AD and Sebti SM. (1998). Mol. Cell. Biol., 18, 6962-6970.
3. Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW and Scher HI. (1999). J. Natl. Cancer Inst., 91, 1869-1876.
4. Aktories K and Just I. (1995). Trends Cell Biol., 5, 441-443.
5. Auer KL, Park J-S, Seth P, Coffey RJ, Darlington G, Abo A, McMahon M, DePinho RA, Fisher PB and Dent P. (1998). Biochem. J., 336, 551-560.
6. Bao W, Thullberg M, Zhang H, Onischenko A and Stromblad S. (2002). Mol. Cell. Biol., 22, 4587-4597.
7. Benard V, Bohl BP and Bokoch GM. (1999). J. Biol. Chem., 274, 13198-13204.
8. Carroll AG, Voeller HJ, Sugars L and Gelmann EP. (1993). Prostate, 23, 123-134.
9. Chen H, Pong RC, Wang Z and Hsieh JT. (2002). Genomics, 79, 573-581.
10. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H and Bostwick DG. (2000). Clin. Cancer Res., 6, 1896-1899.
11. Cipriano SC and Chen YQ. (1998). Oncogene, 17, 1549.
12. Clark EA, Golub TR, Lander ES and Hynes RO. (2000). Nature, 406, 532-535.
13. Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Ordonez NG, Troncoso P and Navone NM. (2002). Clin. Cancer Res., 8, 775-781.
14. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M and Hurwitz J. (1994). Proc. Natl. Acad. Sci. USA, 91, 8655-8659.
15. Gartel AL and Tyner AL. (1999). Exp. Cell Res., 246, 280-289.
16. Ghosh PM, Bedolla R, Mikhailova M and Kreisberg JI. (2002). Cancer Res., 62, 2630-2636.
17. Ghosh PM, Ghosh-Choudhury N, Moyer ML, Mott GE, Thomas CA, Foster BA, Greenberg NM and Kreisberg JI. (1999). Oncogene, 18, 4120-4130.
18. Gille H and Downward J. (1999). J. Biol. Chem., 274, 22033-22040.
19. Gjoerup O, Lukas J, Bartek J and Willumsen B. (1998). J. Biol. Chem., 272, 18812-18818.
20. Guo Y, Sklar GN, Borkowski A and Kyprianou N. (1997). Clin. Cancer Res., 12, 2269-2274.
21. Gupta S, Campbell D, Derijard B and Davis RJ. (1995). Science, 267, 389-393.
22. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP. (1983). Cancer Res., 43, 1809-1818.
23. Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA and Clapp DW. (2001). J. Exp. Med., 194, 57-69.
24. Joyce D, Bouahzah B, Fu M, Albanese C, D'Amico M. Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ and Pestell RG. (1999). J. Biol. Chem., 274, 25245-25249.
25. Kokontis J, Takakura K, Hay N and Liao S. (1994). Cancer Res., 54, 1566-1573.
26. Kokontis JM, Hay N and Liao S. (1998). Mol. Endocrinol., 12, 941-953.
27. Liberto M, Cobrinik D and Minden A. (2002). Oncogene, 21, 1590-1599.
28. Loop SM, Gorder CA, Lewis SM, Saiers JH, Drivdahl RH and Ostenson RC. (1995). Prostate, 26, 179-188.
29. Loop SM, Rozanski TA and Ostenson RC. (1993). Prostate, 22, 93-108.
30. Luo Y, Hurwitz J and Massague J. (1995). Nature, 375, 159-161.
31. Matsushima H, Sasaki T, Goto T, Hosaka Y, Homma Y, Kitamura T, Kawabe K, Sakamoto A, Murakami T and Machinami R. (1998). Hum. Pathol., 29, 778-783.
32. Michiels F, Habets GG, Stam JC, van der Kammen RA and Collard JG. (1995). Nature, 375, 338-340.
33. Minden A, Lin A, Claret F-X, Abo A and Karin M. (1995). Cell, 81, 1147-1157.
34. Mira JP, Benard V, Groffen J, Sanders LC and Knaus UG. (2000). Proc. Natl. Acad. Sci. USA, 97, 185-189.
35. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA and Friedman SL. (2001). Science, 294, 2563-2566.
36. Navone NM, Logothetis CJ, von Eschenbach AC and Troncoso P. (1998-99). Cancer Metast. Rev., 17, 361-371.
37. Olsen MF, Ashworth A and Hall A. (1995). Science, 269, 1270-1272.
38. Olsen MF, Paterson HF and Marshall CJ. (1998). Nature, 394, 295-298.
39. Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR and Hershenson MB. (1999). J Biol Chem, 274, 22065-22071.
40. Qiu R-G, Chen J, Kirn D, McCormick F and Symons M. (1995). Nature, 374, 457-459.
41. Reed N and Gutmann DH. (2001). Trends Mol. Med., 7, 157-162.
42. Rubin SJ, Hallahan DE, Ashman CR, Brachman DG, Beckett MA, Virudachalam S, Yandell DW and Weichselbaum RR. (1991). J. Surg. Oncol., 46, 31-36.
43. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: New York.
44. Sekine A, Fujiwara M and Narumiya S. (1989). J. Biol. Chem., 264, 8602-8605.
45. Sherr CJ. (1996). Science, 274, 1672-1677.
46. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 1501-1512.
47. Shiohara M, el-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B and Koeffler HP. (1994). Blood, 84, 3781-3784.
48. Stahle-Backdhal M, Inoue M, Zedenius J, Sandstedt B, DeMarco L, Flam F, Silfversward C, Andrade J and Friedman E. (1995). Am. J. Pathol., 146, 1073-1078.
49. Tilley WD, Wilson CM, Marcelli M and McPhaul MJ. (1990). Cancer Res., 15, 5382-5386.
50. Tsihlias J, Kapusta L and Slingland J. (1999). Annu. Rev. Med., 50, 401-423.
51. Umekita Y, Hiipakka RA, Kokontis JM and Liao S. (1996). Proc. Natl. Acad. Sci. USA, 93, 11802-11807.
52. Van Aelst L and D'Souza-Schorey C. (1997). Genes Dev., 11, 2295-2322.
53. van Bokhoven A, Varella-Garcia M, Korch C, Hessels D and Miller GJ. (2001). Prostate, 47, 36-51.
54. van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP and Merajver SD. (1999). Clin. Cancer Res., 5, 2511-2519.
55. van Golen KL, Wu ZF, Qiao XT, Bao LW and Merajver SD. (2000). Cancer Res., 60, 5832-5838.
56. Vogt A, Sun J, Qian Y, Hamilton AD and Sebti SM. (1997). J. Biol. Chem., 272, 27224-27229.
57. Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 369, 574-578.
58. Waltregny D, Leav I, Signoretti S, Soung P, Lin D, Merk F, Adams JY, Bhattacharya N, Cirenei N and Loda M. (2001). Mol. Endocrinol., 15, 765-782.
59. Welsh CF and Assoian RK. (2000). Biochim. Biophys. Acta, 1471, M21-M29.
60. Welsh CF, Roovers KR, Villanueva JV, Liu Y, Schwartz MA and Assoian RK. (2001). Nat. Cell Biol., 3, 950-957.
61. Westwick JK, Lambert QT, Clark GJ, Symons M, Van Aelst L, Pestell RG and Der CJ. (1997). Mol. Cell. Biol., 17, 1324-1335.
62. Yang ES, Maiorino CA, Roos BA, Knight SR and Burnstein KL. (2002). Mol. Cell. Endocrinol., 186, 69-79.
63. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ and Bokoch GM. (1995). J. Biol. Chem., 270, 23934-23936.
64. Zhuang S-H and Burnstein KL. (1998). Endocrinology, 139, 1197-1207.
65. Zohn IM, Campbell SL, Khosravi-Far R and Rossman Der CI. (1998). Oncogene, 17, 1415-1438.